Read about the latest developments in RECOVER

Lockdown as a last resort option in case of COVID-19 epidemic rebound

A new RECOVER study developed a modelling framework to help policymakers assess the use of lockdown as a last resort option, by determining when a lockdown should be adopted to avoid passing a predetermined ICU capacity target and by evaluating situations where a slowly growing epidemic might remain manageable for the healthcare system without the need for a lockdown.

Read More »

RECOVER study shows transformation of primary care during COVID-19 pandemic

In May 2021, the RECOVER Social Science team has published a new study in British Journal of General Practice exploring the experiences of primary care healthcare professionals’ (PCPs) during the first peak of COVID-19 pandemic. The study was conducted in eight European countries: England, Belgium, the Netherlands, Ireland, Germany, Poland, Greece, and Sweden, and shows the transformation of primary care during the first wave of the COVID-19 pandemic.

Read More »

Marking one year of RECOVER

RECOVER was initiated as a means to directly tackle the COVID-19 pandemic by acting as PREPARE’s Mode 3 response, the highest response Mode. RECOVER is one of the 18 projects that the European Union has founded in response to the COVID-19 pandemic. It brings together leading scientists and research institutions to obtain crucial unknown information about the disease through clinical research in order to help the EU fight the virus and save patients’ lives. Now, it is time to look back on one year of RECOVER and what we have achieved so far.

Read More »

RECOVER Social Science study: people could better protect themselves from COVID-19 in their own home

In March 2021, the RECOVER Social Science team has published a paper on the experiences and needs of persons living with a household member infected with SARS-CoV-2. Households are important sites for transmission of SARS-CoV-2 and preventive measures are recommended. This study aimed to investigate the impact of living with a person infected with SARS-CoV-2, understand how household members implemented infection control recommendations in their home, and identify the information and support needs of household members.

Read More »

The third point prevalence audit survey captures information on care delivery and patient management during COVID-19 pandemic

The delivery of primary health care, especially for patients with symptoms of a respiratory tract infection, has been highly affected by the COVID-19 pandemic. Preventive measures, frequently changing advice and guidelines, implementation of diagnostic testing by general practices and later by routine community surveillance, changed consultation behaviours because of fear for COVID-19 and not wanting to unnecessarily use health care resources urged for constant adaptations in care delivery.

Read More »

REMAP-CAP published results on tocilizumab and sarilumab in COVID-19 patients

On February 25, the REMAP-CAP paper: “Interleukin-6 Receptor Antagonists in Critically Ill Patients with COVID-19” was published in the New England Journal of Medicine. It shows the results of the use of tocilizumab and sarilumab in patients with severe COVID-19. Adult patients with COVID-19 who received organ support in the intensive care unit within 24 hours, were randomly assigned to receive tocilizumab, sarilumab, or standard care. The publication shows that in critically ill patients with COVID-19 receiving organ support in ICUs, treatment with the interleukin-6 receptor antagonists tocilizumab and sarilumab improved outcomes, including survival.

Read More »